Loomis Sayles Strategic Alpha Fund BMY Holdings History
Loomis Sayles Strategic Alpha Fund's Bristol-Myers Squibb Co Holding Summary
As of 2025-03-31, Natixis Funds Trust II held 2,011.00 shares of Bristol-Myers Squibb Co(BMY), totaling $122,650.00. This investment constitutes 1.11% of their stock portfolio, and Natixis Funds Trust II now holds 0% of the outstanding Bristol-Myers Squibb Co(BMY) stock.
The initial trade took place in 2019Q3. And since then Loomis Sayles Strategic Alpha Fund has made 9 purchases of BMY, at an average price of $53.43, for a total of 25,899.00 shares. In addition, there have been 7 sales at an average price of $62.01 for 23,888.00 shares. Based on historical transaction data and BMY's current price of $48.02, Loomis Sayles Strategic Alpha Fund's estimated gain on his BMY holdings is $193,911.68, reflecting a 14.01% gain to date.
Loomis Sayles Strategic Alpha Fund BMY ($48.02) Holding Chart
Loomis Sayles Strategic Alpha Fund BMY ($48.02) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
